Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B. Garel B, et al. Among authors: caux f. Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4. Br J Clin Pharmacol. 2019. PMID: 30511379 Free PMC article.
A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid.
Alexandre M, Brette MD, Pascal F, Tsianakas P, Fraitag S, Doan S, Caux F, Dupuy A, Heller M, Lièvre N, Lepage V, Dubertret L, Laroche L, Prost-Squarcioni C. Alexandre M, et al. Among authors: caux f. Medicine (Baltimore). 2006 Jul;85(4):239-252. doi: 10.1097/01.md.0000231954.08350.52. Medicine (Baltimore). 2006. PMID: 16862049 Free article.
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, Tancrede-Bohin E, Sassolas B, Lok C, Guillaume JC, Doutre MS, Richard MA, Caux F, Prost C, Plantin P, Chosidow O, Pauwels C, Maillard H, Saiag P, Descamps V, Chevrant-Breton J, Dereure O, Hellot MF, Esteve E, Bernard P. Joly P, et al. Among authors: caux f. J Invest Dermatol. 2009 Jul;129(7):1681-7. doi: 10.1038/jid.2008.412. Epub 2009 Jan 29. J Invest Dermatol. 2009. PMID: 19177141 Free article. Clinical Trial.
Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, Caux F, Pascal F, Doan S, Brette MD, Soued I, Gabison É, Aucouturier F, Letestu R, Laroche L, Bachelez H. Le Roux-Villet C, et al. Among authors: caux f. Arch Dermatol. 2011 Jul;147(7):843-9. doi: 10.1001/archdermatol.2011.54. Epub 2011 Mar 21. Arch Dermatol. 2011. PMID: 21422323
Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita.
Zumelzu C, Le Roux-Villet C, Loiseau P, Busson M, Heller M, Aucouturier F, Pendaries V, Lièvre N, Pascal F, Brette MD, Doan S, Charron D, Caux F, Laroche L, Petit A, Prost-Squarcioni C. Zumelzu C, et al. Among authors: caux f. J Invest Dermatol. 2011 Dec;131(12):2386-93. doi: 10.1038/jid.2011.231. Epub 2011 Aug 11. J Invest Dermatol. 2011. PMID: 21833018 Free article.
Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.
Munyangango EM, Le Roux-Villet C, Doan S, Pascal F, Soued I, Alexandre M, Heller M, Lièvre N, Aucouturier F, Caux F, Laroche L, Prost-Squarcioni C. Munyangango EM, et al. Among authors: caux f. Br J Dermatol. 2013 Feb;168(2):381-90. doi: 10.1111/bjd.12041. Br J Dermatol. 2013. PMID: 22963186
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013.
Sbidian E, Hotz C, Seneschal J, Maruani A, Amelot F, Aubin F, Paul C, Beylot Barry M, Humbert P, Dupuy A, Caux F, Dupin N, Modiano P, Lepesant P, Ingen-Housz-Oro S, Mahé E, Bachelez H, Chosidow O, Wolkenstein P. Sbidian E, et al. Among authors: caux f. Br J Dermatol. 2016 Mar;174(3):667-70. doi: 10.1111/bjd.14199. Epub 2015 Dec 22. Br J Dermatol. 2016. PMID: 26406350 Free article. No abstract available.
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.
Boulard C, Duvert Lehembre S, Picard-Dahan C, Kern JS, Zambruno G, Feliciani C, Marinovic B, Vabres P, Borradori L, Prost-Squarcioni C, Labeille B, Richard MA, Ingen-Housz-Oro S, Houivet E, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; International Pemphigus Study Group. Boulard C, et al. Br J Dermatol. 2016 Jul;175(1):142-9. doi: 10.1111/bjd.14405. Epub 2016 Apr 3. Br J Dermatol. 2016. PMID: 26800395 Free article.
Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).
Seta V, Aucouturier F, Bonnefoy J, Le Roux-Villet C, Pendaries V, Alexandre M, Grootenboer-Mignot S, Heller M, Lièvre N, Laroche L, Caux F, Titeux M, Hovnanian A, Prost-Squarcioni C. Seta V, et al. Among authors: caux f. J Am Acad Dermatol. 2016 Jun;74(6):1166-72. doi: 10.1016/j.jaad.2016.01.005. Epub 2016 Mar 3. J Am Acad Dermatol. 2016. PMID: 26947449
177 results